Alzheimer’s disease and disseminated mycoses

Alzheimer’s disease (AD) is characterized by the presence in the brain of amyloid plaques and neurofibrillary tangles that provoke neuronal cell death, vascular dysfunction and inflammatory processes. In the present work, we have analyzed the existence of fungal infection in AD patients. A number of tests have been carried out in blood serum, including the detection of antibodies against several yeast species and fungal proteins, and also the presence of fungal (1,3)-β-glucan. Results from this analysis indicate that there is disseminated fungal infection in the majority of AD patients tested. Of interest, several AD patients contain high levels of fungal polysaccharides in peripheral blood, reflecting that disseminated fungal infection occurs in these patients. Together, these results suggest the presence of disseminated mycoses in blood serum from AD patients. To our knowledge these findings represent the first evidence that fungal infection is detectable in blood samples in AD patients. The possibility that this may represent a risk factor or may contribute to the etiological cause of AD is discussed.

[1]  Henrik Zetterberg,et al.  Alzheimer's disease , 2006, The Lancet.

[2]  O. Lortholary,et al.  β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[4]  R. Martins,et al.  Infection and Alzheimer's Disease: The APOE ε4 Connection and Lipid Metabolism , 2008 .

[5]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Pablo Martínez-Martín,et al.  Alzheimer Center Reina Sofia Foundation: fighting the disease and providing overall solutions. , 2010, Journal of Alzheimer's disease : JAD.

[7]  B. Hyman,et al.  The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.

[8]  G. Schellenberg,et al.  Developmental and vascular risk factors for Alzheimer's disease , 2005, Neurobiology of Aging.

[9]  C. Christiansen,et al.  The implications of body fat mass and fat distribution for cognitive function in elderly women. , 2004, Obesity research.

[10]  Martin Ingelsson,et al.  The Alzheimer's Disease-Associated Amyloid \(\beta\)-Protein Is an Antimicrobial Peptide , 2010 .

[11]  A. Schmidtchen,et al.  Antimicrobial activity of peptides derived from human ß‐amyloid precursor protein , 2012, Journal of peptide science : an official publication of the European Peptide Society.

[12]  D. Appelt,et al.  Infiltration of the brain by pathogens causes Alzheimer’s disease , 2004, Neurobiology of Aging.

[13]  R. Akinyemi,et al.  Does vascular pathology contribute to Alzheimer changes? , 2012, Journal of the Neurological Sciences.

[14]  H. Tamura,et al.  Determination of plasma (1-->3)-beta-D-glucan: a new diagnostic aid to deep mycosis. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[15]  R. Doss,et al.  Reversible dementia: a case of cryptococcal meningitis masquerading as Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[16]  R. Barraquer,et al.  Fungal Infection in Patients with Serpiginous Choroiditis or Acute Zonal Occult Outer Retinopathy , 2007, Journal of Clinical Microbiology.

[17]  J. Jhamandas,et al.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. , 2013, Journal of psychiatry & neuroscience : JPN.

[18]  M. Tsolaki,et al.  Relationship between Helicobacter pylori infection and Alzheimer disease , 2006, Neurology.

[19]  R. Kalaria.  Similarities between Alzheimer's disease and vascular dementia , 2002, Journal of the Neurological Sciences.

[20]  P. White,et al.  An update on the molecular diagnosis of invasive fungal disease. , 2009, FEMS microbiology letters.

[21]  G. Wilcock,et al.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.

[22]  J. Bockaert,et al.  Alzheimer culprits: cellular crossroads and interplay. , 2012, Cellular signalling.

[23]  Ottavio Arancio,et al.  Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? , 2012, The Biochemical journal.

[24]  Randall J Bateman,et al.  A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system , 2009, Annals of neurology.

[25]  P. Tariot,et al.  A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease , 2011, Neurology.

[26]  M. Hoffmann,et al.  Cryptococcal meningitis misdiagnosed as Alzheimer's disease: complete neurological and cognitive recovery with treatment. , 2009, Journal of Alzheimer's disease : JAD.

[27]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[28]  C. Holmes,et al.  Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications , 2012, CNS neuroscience & therapeutics.

[29]  G. Deepe,et al.  Adaptive immunity to fungi. , 2012, Annual review of immunology.

[30]  D. Pisa,et al.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[31]  R. Tanzi.  The synaptic Abeta hypothesis of Alzheimer disease. , 2005, Nature neuroscience.

[32]  J. Benito-León,et al.  Association between multiple sclerosis and Candida species: evidence from a case-control study , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[33]  A. Palotás,et al.  A New Story about an Old Guy: Is Alzheimer’s Disease Infectious? , 2010, Neurodegenerative Diseases.

[34]  Rusha Shah.  The role of nutrition and diet in Alzheimer disease: a systematic review. , 2013, Journal of the American Medical Directors Association.

[35]  P. Barberger-Gateau,et al.  Dietary patterns and risk of dementia , 2007, Neurology.

[36]  L. Provinciali,et al.  Alzheimer's disease and diabetes: new insights and unifying therapies. , 2013, Current diabetes reviews.

[37]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[38]  Luis Carrasco,et al.  Isolation of Candida famata from a Patient with Acute Zonal Occult Outer Retinopathy , 2005, Journal of Clinical Microbiology.

[39]  J. Pontón,et al.  Contribution of (1→3)-β-d-Glucan Chromogenic Assay to Diagnosis and Therapeutic Monitoring of Invasive Aspergillosis in Neutropenic Adult Patients: a Comparison with Serial Screening for Circulating Galactomannan , 2005, Journal of Clinical Microbiology.

[40]  R. Martins,et al.  Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. , 2008, Journal of Alzheimer's disease : JAD.

[41]  V. Deramecourt,et al.  Staging and natural history of cerebrovascular pathology in dementia , 2012, Neurology.

[42]  R. Martins,et al.  Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes , 2006, Neurobiology of Aging.

[43]  R. Tanzi.  The synaptic Aβ hypothesis of Alzheimer disease , 2005, Nature Neuroscience.

[44]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[45]  H. Tamura,et al.  Determination of plasma (1 → 3)-β-d-glucan: A new diagnostic aid to deep mycosis , 1992 .

[46]  Tuula Pirttilä,et al.  Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells , 2012, Journal of Neuroinflammation.

[47]  L. Ostrosky-Zeichner.  Invasive mycoses: diagnostic challenges. , 2012, The American journal of medicine.

[48]  Luis Carrasco,et al.  Fungal infection in a patient with multiple sclerosis , 2011, European Journal of Clinical Microbiology & Infectious Diseases.